title: Subcutaneous versus intravenous recombinant human erythropoietin administration in hemodialysis patients.
authors.forename: M
authors.initials: M
authors.lastname: Boran
authors.forename: I
authors.initials: I
authors.lastname: Dalva
authors.forename: A
authors.initials: A
authors.lastname: Yazicioğlu
authors.forename: S
authors.initials: S
authors.lastname: Cetin
mesh_terms: D000740:Anemia / Q000188:drug therapy; D004921:Erythropoietin / Q000008:administration & dosage* / Q000627:therapeutic use; D006801:Humans; D007275:Injections, Intravenous; D007279:Injections, Subcutaneous; D007676:Kidney Failure, Chronic / Q000150:complications / Q000628:therapy; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000627:therapeutic use; D006435:Renal Dialysis / Q000379:methods*
chemical_list: D011994:Recombinant Proteins; D004921:Erythropoietin